Since attending ASH in 2016,  I’ve been interested in better understanding the ongoing plight to improve outcomes and assure that all patient benefit equally from advances in treatment. Each year, researchers address disparities impacting care of multiple myeloma patients. In addition to numerous scientific oral presentations, I had the opportunity to attend an interesting paper […]